Literature DB >> 31611287

Acellular mucin in pseudomyxoma peritonei of appendiceal origin: what is adequate sampling for histopathology?

Marwa Al-Azzawi1, Joseph Misdraji2, Marie-Louise F van Velthuysen3, Jinru Shia4, Melissa W Taggart5, Rhonda K Yantiss6, Magali Svrcek7, Norman Carr8.   

Abstract

INTRODUCTION: Acellular intra-abdominal mucin is associated with a favourable prognosis in pseudomyxoma peritonei. There are no current guidelines on how many blocks are needed to classify the mucin as acellular with confidence.
METHODS: Specimens from cytoreductive surgery for mucinous appendiceal neoplasia, in which acellular mucin was found on initial histopathological examination, were prospectively identified. Additional tissue blocks were then taken to include either all residual visible intra-abdominal mucin or a maximum of 30 blocks. We also sent a questionnaire to pathologists in other centres.
RESULTS: Twelve patients were identified. In two cases, neoplastic epithelial cells were found on taking additional blocks. The questionnaire results suggested considerable variation in block-taking practice.
CONCLUSION: Taking additional tissue identified neoplastic cells in 2 of 12 cases. We recommend that sampling additional material should be considered when only acellular mucin is found on initial histology. Further work to determine the optimum sampling protocol is indicated. © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  appendix; histopathology; malignant tumours; peritoneum

Year:  2019        PMID: 31611287     DOI: 10.1136/jclinpath-2019-206213

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  5 in total

1.  From the Ronnett to the PSOGI Classification System for Pseudomyxoma Peritonei: A Validation Study.

Authors:  Blanca Rufián-Andujar; Francisca Valenzuela-Molina; Sebastián Rufián-Peña; Ángela Casado-Adam; Juan Manuel Sánchez-Hidalgo; Lidia Rodríguez-Ortiz; Francisco Javier Medina-Fernández; Cesar Díaz-López; Rosa Ortega-Salas; Ana Martínez-López; Javier Briceño-Delgado; Antonio Romero-Ruíz; Álvaro Arjona-Sánchez
Journal:  Ann Surg Oncol       Date:  2021-01-20       Impact factor: 5.344

2.  Validating the PSOGI classification of peritoneal disease from non-carcinoid epithelial appendiceal neoplasms in the curative and palliative setting: an observational retrospective study.

Authors:  Nina Farrokhnia; Henrik Benoni; Lana Ghanipour; Peter H Cashin
Journal:  J Gastrointest Oncol       Date:  2022-04

3.  Overall Survival is More Closely Associated with Peritoneal than Primary Appendiceal Pathological Grade in Pseudomyxoma Peritonei with Discordant Pathology.

Authors:  Ayaz Ahmed Memon; Chintamani Godbole; Tom Cecil; Sanjeev Dayal; Brendan Moran; Alexios Tzivanakis; Faheez Mohamed; Norman J Carr
Journal:  Ann Surg Oncol       Date:  2021-11-03       Impact factor: 5.344

4.  ASO Author Reflections: Discordant Pathology in Pseudomyxoma Peritonei and Its Impact on Survival following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.

Authors:  Chintamani Godbole; Ayaz Ahmed Memon; Norman John Carr
Journal:  Ann Surg Oncol       Date:  2021-11-05       Impact factor: 5.344

5.  Updated staging and patient outcomes in low-grade appendiceal mucinous neoplasms.

Authors:  Samuel J Ballentine; Jacquelyn Carr; Eliahu Y Bekhor; Umut Sarpel; Alexandros D Polydorides
Journal:  Mod Pathol       Date:  2020-07-29       Impact factor: 7.842

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.